{
    "query": {
        "id": null,
        "referenceGenome": "GRCh37",
        "hugoSymbol": "TP53",
        "entrezGeneId": 7157,
        "alteration": "Deletion",
        "alterationType": "MUTATION",
        "svType": null,
        "tumorType": null,
        "consequence": "NA",
        "proteinStart": -1,
        "proteinEnd": 100000,
        "hgvs": null
    },
    "geneExist": true,
    "variantExist": true,
    "alleleExist": false,
    "oncogenic": "Likely Oncogenic",
    "mutationEffect": {
        "knownEffect": "Likely Loss-of-function",
        "description": "TP53 deletions are predicted to be inactivating and associated with poor prognosis (PMID: 11900253, 20697090, 21467160, 12584563). Experimental studies have revealed that deletions result in loss of TP53 tumor suppressive function, since TP53 cannot decrease cell viability in vitro (PMID: 27759562). Additionally, deletion of TP53 in the neurons of mice, while not sufficient to cause tumor development, allows the accumulation of other oncogenic mutations leading to tumorigenesis (PMID: 19477430). Further, loss of TP53 protein during 17p deletion events in leukemia/lymphoma, enhances cancer development through cooperation of linked tumor suppressive genes such as EIF5A and ALOX15B (PMID: 26982726).",
        "citations": {
            "pmids": [
                "26982726",
                "20697090",
                "27759562",
                "19477430",
                "11900253",
                "12584563",
                "21467160"
            ],
            "abstracts": []
        }
    },
    "highestSensitiveLevel": null,
    "highestResistanceLevel": null,
    "highestDiagnosticImplicationLevel": null,
    "highestPrognosticImplicationLevel": "LEVEL_Px1",
    "highestFdaLevel": null,
    "otherSignificantSensitiveLevels": [],
    "otherSignificantResistanceLevels": [],
    "hotspot": false,
    "geneSummary": "TP53, a tumor suppressor in the DNA damage pathway, is the most frequently mutated gene in cancer.",
    "variantSummary": "TP53 deletion is likely oncogenic.",
    "tumorTypeSummary": "",
    "prognosticSummary": "",
    "diagnosticSummary": "",
    "diagnosticImplications": [],
    "prognosticImplications": [
        {
            "levelOfEvidence": "LEVEL_Px1",
            "alterations": [
                "Deletion"
            ],
            "tumorType": {
                "id": 645,
                "code": "PCM",
                "color": "LimeGreen",
                "name": "Plasma Cell Myeloma",
                "mainType": {
                    "id": null,
                    "name": "Mature B-Cell Neoplasms",
                    "tumorForm": "LIQUID"
                },
                "tissue": "Lymphoid",
                "children": {},
                "parent": "MBN",
                "level": 5,
                "tumorForm": "LIQUID"
            },
            "pmids": [
                "17209057",
                "9680348",
                "18337559"
            ],
            "abstracts": [
                {
                    "link": "http://www.bloodjournal.org/content/128/22/3271?sso-checked=true",
                    "abstract": "Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017"
                }
            ],
            "description": "This assertion is supported by (PMID: 9680348, 18337559, 17209057 Abstract: Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017. http://www.bloodjournal.org/content/128/22/3271?sso-checked=true; http://www.bloodjournal.org/content/122/21/1846)."
        },
        {
            "levelOfEvidence": "LEVEL_Px1",
            "alterations": [
                "Oncogenic Mutations"
            ],
            "tumorType": {
                "id": 17,
                "code": "AMLMRC",
                "color": "LightSalmon",
                "name": "AML with Myelodysplasia-Related Changes",
                "mainType": {
                    "id": null,
                    "name": "Leukemia",
                    "tumorForm": "LIQUID"
                },
                "tissue": "Myeloid",
                "children": {},
                "parent": "AML",
                "level": 4,
                "tumorForm": "LIQUID"
            },
            "pmids": [
                "25412851",
                "25860933"
            ],
            "abstracts": [],
            "description": "This assertion is supported by (PMID: 25860933, 25412851)."
        },
        {
            "levelOfEvidence": "LEVEL_Px1",
            "alterations": [
                "Oncogenic Mutations"
            ],
            "tumorType": {
                "id": 527,
                "code": "AML",
                "color": "LightSalmon",
                "name": "Acute Myeloid Leukemia",
                "mainType": {
                    "id": null,
                    "name": "Leukemia",
                    "tumorForm": "LIQUID"
                },
                "tissue": "Myeloid",
                "children": {},
                "parent": "MNM",
                "level": 3,
                "tumorForm": "LIQUID"
            },
            "pmids": [
                "22186996",
                "18596741"
            ],
            "abstracts": [],
            "description": "This assertion is supported by (PMID: 22186996, 18596741)."
        },
        {
            "levelOfEvidence": "LEVEL_Px1",
            "alterations": [
                "Oncogenic Mutations"
            ],
            "tumorType": {
                "id": 418,
                "code": "TMN",
                "color": "LightSalmon",
                "name": "Therapy-Related Myeloid Neoplasms",
                "mainType": {
                    "id": null,
                    "name": "Leukemia",
                    "tumorForm": "LIQUID"
                },
                "tissue": "Myeloid",
                "children": {},
                "parent": "AML",
                "level": 4,
                "tumorForm": "LIQUID"
            },
            "pmids": [
                "25412846",
                "25952993"
            ],
            "abstracts": [],
            "description": "This assertion is supported by (PMID: 25412846, 25952993)."
        },
        {
            "levelOfEvidence": "LEVEL_Px1",
            "alterations": [
                "Oncogenic Mutations"
            ],
            "tumorType": {
                "id": 533,
                "code": "CLLSLL",
                "color": "LimeGreen",
                "name": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
                "mainType": {
                    "id": null,
                    "name": "Mature B-Cell Neoplasms",
                    "tumorForm": "LIQUID"
                },
                "tissue": "Lymphoid",
                "children": {},
                "parent": "MBN",
                "level": 5,
                "tumorForm": "LIQUID"
            },
            "pmids": [
                "23243274",
                "24004666",
                "20697090",
                "19188171",
                "24652989"
            ],
            "abstracts": [],
            "description": "This assertion is supported by (PMID: 19188171, 20697090, 24652989, 23243274, 24004666)."
        },
        {
            "levelOfEvidence": "LEVEL_Px1",
            "alterations": [
                "Oncogenic Mutations"
            ],
            "tumorType": {
                "id": 355,
                "code": "MDS",
                "color": "LightSalmon",
                "name": "Myelodysplastic Syndromes",
                "mainType": {
                    "id": null,
                    "name": "Myelodysplastic Syndromes",
                    "tumorForm": "LIQUID"
                },
                "tissue": "Myeloid",
                "children": {},
                "parent": "MNM",
                "level": 3,
                "tumorForm": "LIQUID"
            },
            "pmids": [
                "21714648",
                "25092778",
                "24220272"
            ],
            "abstracts": [],
            "description": "This assertion is supported by (PMID: 24220272, 21714648, 25092778)."
        },
        {
            "levelOfEvidence": "LEVEL_Px1",
            "alterations": [
                "Oncogenic Mutations"
            ],
            "tumorType": {
                "id": 695,
                "code": "ET",
                "color": "LightSalmon",
                "name": "Essential Thrombocythemia",
                "mainType": {
                    "id": null,
                    "name": "Myeloproliferative Neoplasms",
                    "tumorForm": "LIQUID"
                },
                "tissue": "Myeloid",
                "children": {},
                "parent": "MPN",
                "level": 4,
                "tumorForm": "LIQUID"
            },
            "pmids": [
                "24478400",
                "29296692",
                "22887079"
            ],
            "abstracts": [],
            "description": "This assertion is supported by (PMID: 22887079, 29296692, 24478400)."
        },
        {
            "levelOfEvidence": "LEVEL_Px1",
            "alterations": [
                "Oncogenic Mutations"
            ],
            "tumorType": {
                "id": 185,
                "code": "MPN",
                "color": "LightSalmon",
                "name": "Myeloproliferative Neoplasms",
                "mainType": {
                    "id": null,
                    "name": "Myeloproliferative Neoplasms",
                    "tumorForm": "LIQUID"
                },
                "tissue": "Myeloid",
                "children": {},
                "parent": "MNM",
                "level": 3,
                "tumorForm": "LIQUID"
            },
            "pmids": [
                "25516983",
                "22052707",
                "22887079"
            ],
            "abstracts": [],
            "description": "This assertion is supported by (PMID: 22887079, 25516983, 22052707)."
        },
        {
            "levelOfEvidence": "LEVEL_Px1",
            "alterations": [
                "Oncogenic Mutations"
            ],
            "tumorType": {
                "id": 632,
                "code": "PMF",
                "color": "LightSalmon",
                "name": "Primary Myelofibrosis",
                "mainType": {
                    "id": null,
                    "name": "Myeloproliferative Neoplasms",
                    "tumorForm": "LIQUID"
                },
                "tissue": "Myeloid",
                "children": {},
                "parent": "MPN",
                "level": 4,
                "tumorForm": "LIQUID"
            },
            "pmids": [
                "25516983",
                "22052707",
                "22887079"
            ],
            "abstracts": [],
            "description": "This assertion is supported by (PMID: 22887079, 25516983, 22052707)."
        },
        {
            "levelOfEvidence": "LEVEL_Px3",
            "alterations": [
                "Oncogenic Mutations"
            ],
            "tumorType": {
                "id": 586,
                "code": "MCL",
                "color": "LimeGreen",
                "name": "Mantle Cell Lymphoma",
                "mainType": {
                    "id": null,
                    "name": "Mature B-Cell Neoplasms",
                    "tumorForm": "LIQUID"
                },
                "tissue": "Lymphoid",
                "children": {},
                "parent": "MBN",
                "level": 5,
                "tumorForm": "LIQUID"
            },
            "pmids": [
                "8639789",
                "7579380",
                "28819011",
                "24684350",
                "26022239"
            ],
            "abstracts": [],
            "description": "This assertion is supported by (PMID: 28819011, 26022239, 24684350, 8639789, 7579380)."
        }
    ],
    "treatments": [],
    "dataVersion": "V4.3",
    "lastUpdate": "07/18/2019",
    "background": "TP53 encodes the p53 tumor suppressor protein, a transcription factor that responds to cellular stresses, including DNA damage and oncogenic activation, by inducing downstream anti-tumor responses such as DNA repair and apoptosis (PMID: 11099028). TP53 is the most commonly mutated gene in human cancers, and germline mutations occur in the cancer predisposition syndrome Li-Fraumeni (PMID: 22713868, 21765642). The p53 protein consists of an N-terminal transactivation domain, a central DNA-binding domain, an oligomerization domain and a C-terminal regulatory domain (PMID: 22713868).",
    "tumorTypes": [
        {
            "relevantTumorType": false,
            "tumorType": {
                "id": 17,
                "subtype": "AML with Myelodysplasia-Related Changes",
                "code": "AMLMRC",
                "color": "LightSalmon",
                "mainType": "Leukemia",
                "level": 4,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            },
            "evidences": [
                {
                    "id": 25654,
                    "uuid": "ee6b8c2d-0e7a-42bb-ab8f-ef29344cd081",
                    "evidenceType": "PROGNOSTIC_IMPLICATION",
                    "cancerTypes": [
                        {
                            "id": 17,
                            "subtype": "AML with Myelodysplasia-Related Changes",
                            "code": "AMLMRC",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "excludedCancerTypes": [],
                    "relevantCancerTypes": [
                        {
                            "id": 17,
                            "subtype": "AML with Myelodysplasia-Related Changes",
                            "code": "AMLMRC",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "gene": {
                        "entrezGeneId": 7157,
                        "hugoSymbol": "TP53",
                        "grch37Isoform": "ENST00000269305",
                        "grch37RefSeq": "NM_000546.5",
                        "grch38Isoform": "ENST00000269305",
                        "grch38RefSeq": "NM_000546.5",
                        "geneAliases": [
                            "LFS1",
                            "p53"
                        ],
                        "genesets": [],
                        "geneType": "TSG"
                    },
                    "alterations": [
                        {
                            "gene": {
                                "entrezGeneId": 7157,
                                "hugoSymbol": "TP53",
                                "grch37Isoform": "ENST00000269305",
                                "grch37RefSeq": "NM_000546.5",
                                "grch38Isoform": "ENST00000269305",
                                "grch38RefSeq": "NM_000546.5",
                                "geneAliases": [
                                    "LFS1",
                                    "p53"
                                ],
                                "genesets": [],
                                "geneType": "TSG"
                            },
                            "consequence": {
                                "term": "NA",
                                "isGenerallyTruncating": false,
                                "description": "NA"
                            },
                            "alteration": "Oncogenic Mutations",
                            "name": "Oncogenic Mutations",
                            "refResidues": null,
                            "proteinStart": -1,
                            "proteinEnd": 100000,
                            "variantResidues": null,
                            "referenceGenomes": [
                                "GRCh38",
                                "GRCh37"
                            ]
                        }
                    ],
                    "description": "This assertion is supported by (PMID: 25860933, 25412851).",
                    "additionalInfo": null,
                    "treatments": [],
                    "knownEffect": null,
                    "lastEdit": 1600293135000,
                    "lastReview": null,
                    "levelOfEvidence": "LEVEL_Px1",
                    "fdaLevel": null,
                    "solidPropagationLevel": null,
                    "liquidPropagationLevel": null,
                    "articles": [
                        {
                            "pmid": "25860933",
                            "title": "Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.",
                            "journal": "Oncotarget",
                            "pubDate": "2015 Apr 10",
                            "volume": "6",
                            "issue": "10",
                            "pages": "8388-96",
                            "authors": "Devillier R et al",
                            "elocationId": "",
                            "link": null,
                            "reference": "Devillier R et al. Oncotarget. 2015 Apr 10;6(10)8388-96.",
                            "abstract": null
                        },
                        {
                            "pmid": "25412851",
                            "title": "Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.",
                            "journal": "Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc",
                            "pubDate": "2015 May",
                            "volume": "28",
                            "issue": "5",
                            "pages": "706-14",
                            "authors": "Ohgami RS et al",
                            "elocationId": "doi: 10.1038/modpathol.2014.160",
                            "link": null,
                            "reference": "Ohgami RS et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2015 May;28(5)706-14.",
                            "abstract": null
                        }
                    ]
                }
            ]
        },
        {
            "relevantTumorType": false,
            "tumorType": {
                "id": 418,
                "subtype": "Therapy-Related Myeloid Neoplasms",
                "code": "TMN",
                "color": "LightSalmon",
                "mainType": "Leukemia",
                "level": 4,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            },
            "evidences": [
                {
                    "id": 25658,
                    "uuid": "17eadd11-3a15-408a-853b-121286199008",
                    "evidenceType": "PROGNOSTIC_IMPLICATION",
                    "cancerTypes": [
                        {
                            "id": 418,
                            "subtype": "Therapy-Related Myeloid Neoplasms",
                            "code": "TMN",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "excludedCancerTypes": [],
                    "relevantCancerTypes": [
                        {
                            "id": 418,
                            "subtype": "Therapy-Related Myeloid Neoplasms",
                            "code": "TMN",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 468,
                            "subtype": "Therapy-Related Acute Myeloid Leukemia",
                            "code": "TAML",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 6,
                            "subtype": "Therapy-Related Myelodysplastic Syndrome",
                            "code": "TMDS",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "gene": {
                        "entrezGeneId": 7157,
                        "hugoSymbol": "TP53",
                        "grch37Isoform": "ENST00000269305",
                        "grch37RefSeq": "NM_000546.5",
                        "grch38Isoform": "ENST00000269305",
                        "grch38RefSeq": "NM_000546.5",
                        "geneAliases": [
                            "LFS1",
                            "p53"
                        ],
                        "genesets": [],
                        "geneType": "TSG"
                    },
                    "alterations": [
                        {
                            "gene": {
                                "entrezGeneId": 7157,
                                "hugoSymbol": "TP53",
                                "grch37Isoform": "ENST00000269305",
                                "grch37RefSeq": "NM_000546.5",
                                "grch38Isoform": "ENST00000269305",
                                "grch38RefSeq": "NM_000546.5",
                                "geneAliases": [
                                    "LFS1",
                                    "p53"
                                ],
                                "genesets": [],
                                "geneType": "TSG"
                            },
                            "consequence": {
                                "term": "NA",
                                "isGenerallyTruncating": false,
                                "description": "NA"
                            },
                            "alteration": "Oncogenic Mutations",
                            "name": "Oncogenic Mutations",
                            "refResidues": null,
                            "proteinStart": -1,
                            "proteinEnd": 100000,
                            "variantResidues": null,
                            "referenceGenomes": [
                                "GRCh38",
                                "GRCh37"
                            ]
                        }
                    ],
                    "description": "This assertion is supported by (PMID: 25412846, 25952993).",
                    "additionalInfo": null,
                    "treatments": [],
                    "knownEffect": null,
                    "lastEdit": 1600293135000,
                    "lastReview": null,
                    "levelOfEvidence": "LEVEL_Px1",
                    "fdaLevel": null,
                    "solidPropagationLevel": null,
                    "liquidPropagationLevel": null,
                    "articles": [
                        {
                            "pmid": "25412846",
                            "title": "High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome.",
                            "journal": "Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc",
                            "pubDate": "2015 Apr",
                            "volume": "28",
                            "issue": "4",
                            "pages": "552-63",
                            "authors": "Cleven AH et al",
                            "elocationId": "doi: 10.1038/modpathol.2014.153",
                            "link": null,
                            "reference": "Cleven AH et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2015 Apr;28(4)552-63.",
                            "abstract": null
                        },
                        {
                            "pmid": "25952993",
                            "title": "TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.",
                            "journal": "Journal of hematology & oncology",
                            "pubDate": "2015 May 8",
                            "volume": "8",
                            "issue": "",
                            "pages": "45",
                            "authors": "Ok CY et al",
                            "elocationId": "doi: 10.1186/s13045-015-0139-z",
                            "link": null,
                            "reference": "Ok CY et al. Journal of hematology & oncology. 2015 May 8;8()45.",
                            "abstract": null
                        }
                    ]
                }
            ]
        },
        {
            "relevantTumorType": false,
            "tumorType": {
                "id": 355,
                "subtype": "Myelodysplastic Syndromes",
                "code": "MDS",
                "color": "LightSalmon",
                "mainType": "Myelodysplastic Syndromes",
                "level": 3,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            },
            "evidences": [
                {
                    "id": 25662,
                    "uuid": "4e8b3dca-b8a1-43bf-986a-54d18b445ceb",
                    "evidenceType": "PROGNOSTIC_IMPLICATION",
                    "cancerTypes": [
                        {
                            "id": 355,
                            "subtype": "Myelodysplastic Syndromes",
                            "code": "MDS",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 3,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "excludedCancerTypes": [],
                    "relevantCancerTypes": [
                        {
                            "id": 337,
                            "subtype": "MDS with Ring Sideroblasts and Single Lineage Dysplasia",
                            "code": "MDSRSSLD",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 770,
                            "subtype": "MDS with excess blasts-1",
                            "code": "MDSEB1",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 355,
                            "subtype": "Myelodysplastic Syndromes",
                            "code": "MDS",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 3,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 99,
                            "subtype": "MDS with Isolated Del(5q)",
                            "code": "MDSID5Q",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 227,
                            "subtype": "MDS with Multilineage Dysplasia",
                            "code": "MDSMD",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 709,
                            "subtype": "MDS, Unclassifiable",
                            "code": "MDSU",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 680,
                            "subtype": "Refractory Cytopenia of Childhood",
                            "code": "RCYC",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 840,
                            "subtype": "MDS with Ring Sideroblasts and Multilineage Dysplasia",
                            "code": "MDSRSMD",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 362,
                            "subtype": "MDS with Excess Blasts",
                            "code": "MDSEB",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 378,
                            "subtype": "MDS with excess blasts-2",
                            "code": "MDSEB2",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 267,
                            "subtype": "MDS with Ring Sideroblasts",
                            "code": "MDSRS",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 606,
                            "subtype": "MDS with Single Lineage Dysplasia",
                            "code": "MDSSLD",
                            "color": "LightSalmon",
                            "mainType": "Myelodysplastic Syndromes",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "gene": {
                        "entrezGeneId": 7157,
                        "hugoSymbol": "TP53",
                        "grch37Isoform": "ENST00000269305",
                        "grch37RefSeq": "NM_000546.5",
                        "grch38Isoform": "ENST00000269305",
                        "grch38RefSeq": "NM_000546.5",
                        "geneAliases": [
                            "LFS1",
                            "p53"
                        ],
                        "genesets": [],
                        "geneType": "TSG"
                    },
                    "alterations": [
                        {
                            "gene": {
                                "entrezGeneId": 7157,
                                "hugoSymbol": "TP53",
                                "grch37Isoform": "ENST00000269305",
                                "grch37RefSeq": "NM_000546.5",
                                "grch38Isoform": "ENST00000269305",
                                "grch38RefSeq": "NM_000546.5",
                                "geneAliases": [
                                    "LFS1",
                                    "p53"
                                ],
                                "genesets": [],
                                "geneType": "TSG"
                            },
                            "consequence": {
                                "term": "NA",
                                "isGenerallyTruncating": false,
                                "description": "NA"
                            },
                            "alteration": "Oncogenic Mutations",
                            "name": "Oncogenic Mutations",
                            "refResidues": null,
                            "proteinStart": -1,
                            "proteinEnd": 100000,
                            "variantResidues": null,
                            "referenceGenomes": [
                                "GRCh38",
                                "GRCh37"
                            ]
                        }
                    ],
                    "description": "This assertion is supported by (PMID: 24220272, 21714648, 25092778).",
                    "additionalInfo": null,
                    "treatments": [],
                    "knownEffect": null,
                    "lastEdit": 1600293135000,
                    "lastReview": null,
                    "levelOfEvidence": "LEVEL_Px1",
                    "fdaLevel": null,
                    "solidPropagationLevel": null,
                    "liquidPropagationLevel": null,
                    "articles": [
                        {
                            "pmid": "21714648",
                            "title": "Clinical effect of point mutations in myelodysplastic syndromes.",
                            "journal": "The New England journal of medicine",
                            "pubDate": "2011 Jun 30",
                            "volume": "364",
                            "issue": "26",
                            "pages": "2496-506",
                            "authors": "Bejar R et al",
                            "elocationId": "doi: 10.1056/NEJMoa1013343",
                            "link": null,
                            "reference": "Bejar R et al. The New England journal of medicine. 2011 Jun 30;364(26)2496-506.",
                            "abstract": null
                        },
                        {
                            "pmid": "24220272",
                            "title": "Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.",
                            "journal": "Leukemia",
                            "pubDate": "2014 Feb",
                            "volume": "28",
                            "issue": "2",
                            "pages": "241-7",
                            "authors": "Haferlach T et al",
                            "elocationId": "doi: 10.1038/leu.2013.336",
                            "link": null,
                            "reference": "Haferlach T et al. Leukemia. 2014 Feb;28(2)241-7.",
                            "abstract": null
                        },
                        {
                            "pmid": "25092778",
                            "title": "Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.",
                            "journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
                            "pubDate": "2014 Sep 1",
                            "volume": "32",
                            "issue": "25",
                            "pages": "2691-8",
                            "authors": "Bejar R et al",
                            "elocationId": "doi: 10.1200/JCO.2013.52.3381",
                            "link": null,
                            "reference": "Bejar R et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Sep 1;32(25)2691-8.",
                            "abstract": null
                        }
                    ]
                }
            ]
        },
        {
            "relevantTumorType": false,
            "tumorType": {
                "id": 645,
                "subtype": "Plasma Cell Myeloma",
                "code": "PCM",
                "color": "LimeGreen",
                "mainType": "Mature B-Cell Neoplasms",
                "level": 5,
                "tissue": "Lymphoid",
                "tumorForm": "LIQUID"
            },
            "evidences": [
                {
                    "id": 25678,
                    "uuid": "143077a9-08b8-4800-8c52-db80dad34385",
                    "evidenceType": "PROGNOSTIC_IMPLICATION",
                    "cancerTypes": [
                        {
                            "id": 645,
                            "subtype": "Plasma Cell Myeloma",
                            "code": "PCM",
                            "color": "LimeGreen",
                            "mainType": "Mature B-Cell Neoplasms",
                            "level": 5,
                            "tissue": "Lymphoid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "excludedCancerTypes": [],
                    "relevantCancerTypes": [
                        {
                            "id": 645,
                            "subtype": "Plasma Cell Myeloma",
                            "code": "PCM",
                            "color": "LimeGreen",
                            "mainType": "Mature B-Cell Neoplasms",
                            "level": 5,
                            "tissue": "Lymphoid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "gene": {
                        "entrezGeneId": 7157,
                        "hugoSymbol": "TP53",
                        "grch37Isoform": "ENST00000269305",
                        "grch37RefSeq": "NM_000546.5",
                        "grch38Isoform": "ENST00000269305",
                        "grch38RefSeq": "NM_000546.5",
                        "geneAliases": [
                            "LFS1",
                            "p53"
                        ],
                        "genesets": [],
                        "geneType": "TSG"
                    },
                    "alterations": [
                        {
                            "gene": {
                                "entrezGeneId": 7157,
                                "hugoSymbol": "TP53",
                                "grch37Isoform": "ENST00000269305",
                                "grch37RefSeq": "NM_000546.5",
                                "grch38Isoform": "ENST00000269305",
                                "grch38RefSeq": "NM_000546.5",
                                "geneAliases": [
                                    "LFS1",
                                    "p53"
                                ],
                                "genesets": [],
                                "geneType": "TSG"
                            },
                            "consequence": {
                                "term": "NA",
                                "isGenerallyTruncating": false,
                                "description": "NA"
                            },
                            "alteration": "Deletion",
                            "name": "Deletion",
                            "refResidues": null,
                            "proteinStart": -1,
                            "proteinEnd": 100000,
                            "variantResidues": null,
                            "referenceGenomes": [
                                "GRCh38",
                                "GRCh37"
                            ]
                        }
                    ],
                    "description": "This assertion is supported by (PMID: 9680348, 18337559, 17209057 Abstract: Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017. http://www.bloodjournal.org/content/128/22/3271?sso-checked=true; http://www.bloodjournal.org/content/122/21/1846).",
                    "additionalInfo": null,
                    "treatments": [],
                    "knownEffect": null,
                    "lastEdit": 1600293135000,
                    "lastReview": null,
                    "levelOfEvidence": "LEVEL_Px1",
                    "fdaLevel": null,
                    "solidPropagationLevel": null,
                    "liquidPropagationLevel": null,
                    "articles": [
                        {
                            "pmid": "9680348",
                            "title": "Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy.",
                            "journal": "Blood",
                            "pubDate": "1998 Aug 1",
                            "volume": "92",
                            "issue": "3",
                            "pages": "802-9",
                            "authors": "Drach J et al",
                            "elocationId": "",
                            "link": null,
                            "reference": "Drach J et al. Blood. 1998 Aug 1;92(3)802-9.",
                            "abstract": null
                        },
                        {
                            "pmid": "17209057",
                            "title": "Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.",
                            "journal": "Blood",
                            "pubDate": "2007 Apr 15",
                            "volume": "109",
                            "issue": "8",
                            "pages": "3489-95",
                            "authors": "Avet-Loiseau H et al",
                            "elocationId": "",
                            "link": null,
                            "reference": "Avet-Loiseau H et al. Blood. 2007 Apr 15;109(8)3489-95.",
                            "abstract": null
                        },
                        {
                            "pmid": null,
                            "title": null,
                            "journal": null,
                            "pubDate": null,
                            "volume": null,
                            "issue": null,
                            "pages": null,
                            "authors": null,
                            "elocationId": null,
                            "link": "http://www.bloodjournal.org/content/128/22/3271?sso-checked=true",
                            "reference": "null. null. .",
                            "abstract": "Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017"
                        },
                        {
                            "pmid": "18337559",
                            "title": "An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma.",
                            "journal": "Blood",
                            "pubDate": "2008 Nov 15",
                            "volume": "112",
                            "issue": "10",
                            "pages": "4235-46",
                            "authors": "Xiong W et al",
                            "elocationId": "doi: 10.1182/blood-2007-10-119123",
                            "link": null,
                            "reference": "Xiong W et al. Blood. 2008 Nov 15;112(10)4235-46.",
                            "abstract": null
                        }
                    ]
                }
            ]
        },
        {
            "relevantTumorType": false,
            "tumorType": {
                "id": 533,
                "subtype": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
                "code": "CLLSLL",
                "color": "LimeGreen",
                "mainType": "Mature B-Cell Neoplasms",
                "level": 5,
                "tissue": "Lymphoid",
                "tumorForm": "LIQUID"
            },
            "evidences": [
                {
                    "id": 25660,
                    "uuid": "8d78d7c1-2bf2-4199-9d9b-8fdb688bb9be",
                    "evidenceType": "PROGNOSTIC_IMPLICATION",
                    "cancerTypes": [
                        {
                            "id": 533,
                            "subtype": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
                            "code": "CLLSLL",
                            "color": "LimeGreen",
                            "mainType": "Mature B-Cell Neoplasms",
                            "level": 5,
                            "tissue": "Lymphoid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "excludedCancerTypes": [],
                    "relevantCancerTypes": [
                        {
                            "id": 533,
                            "subtype": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
                            "code": "CLLSLL",
                            "color": "LimeGreen",
                            "mainType": "Mature B-Cell Neoplasms",
                            "level": 5,
                            "tissue": "Lymphoid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "gene": {
                        "entrezGeneId": 7157,
                        "hugoSymbol": "TP53",
                        "grch37Isoform": "ENST00000269305",
                        "grch37RefSeq": "NM_000546.5",
                        "grch38Isoform": "ENST00000269305",
                        "grch38RefSeq": "NM_000546.5",
                        "geneAliases": [
                            "LFS1",
                            "p53"
                        ],
                        "genesets": [],
                        "geneType": "TSG"
                    },
                    "alterations": [
                        {
                            "gene": {
                                "entrezGeneId": 7157,
                                "hugoSymbol": "TP53",
                                "grch37Isoform": "ENST00000269305",
                                "grch37RefSeq": "NM_000546.5",
                                "grch38Isoform": "ENST00000269305",
                                "grch38RefSeq": "NM_000546.5",
                                "geneAliases": [
                                    "LFS1",
                                    "p53"
                                ],
                                "genesets": [],
                                "geneType": "TSG"
                            },
                            "consequence": {
                                "term": "NA",
                                "isGenerallyTruncating": false,
                                "description": "NA"
                            },
                            "alteration": "Oncogenic Mutations",
                            "name": "Oncogenic Mutations",
                            "refResidues": null,
                            "proteinStart": -1,
                            "proteinEnd": 100000,
                            "variantResidues": null,
                            "referenceGenomes": [
                                "GRCh38",
                                "GRCh37"
                            ]
                        }
                    ],
                    "description": "This assertion is supported by (PMID: 19188171, 20697090, 24652989, 23243274, 24004666).",
                    "additionalInfo": null,
                    "treatments": [],
                    "knownEffect": null,
                    "lastEdit": 1600293135000,
                    "lastReview": null,
                    "levelOfEvidence": "LEVEL_Px1",
                    "fdaLevel": null,
                    "solidPropagationLevel": null,
                    "liquidPropagationLevel": null,
                    "articles": [
                        {
                            "pmid": "24652989",
                            "title": "Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.",
                            "journal": "Blood",
                            "pubDate": "2014 May 22",
                            "volume": "123",
                            "issue": "21",
                            "pages": "3247-54",
                            "authors": "Stilgenbauer S et al",
                            "elocationId": "doi: 10.1182/blood-2014-01-546150",
                            "link": null,
                            "reference": "Stilgenbauer S et al. Blood. 2014 May 22;123(21)3247-54.",
                            "abstract": null
                        },
                        {
                            "pmid": "23243274",
                            "title": "Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.",
                            "journal": "Blood",
                            "pubDate": "2013 Feb 21",
                            "volume": "121",
                            "issue": "8",
                            "pages": "1403-12",
                            "authors": "Rossi D et al",
                            "elocationId": "doi: 10.1182/blood-2012-09-458265",
                            "link": null,
                            "reference": "Rossi D et al. Blood. 2013 Feb 21;121(8)1403-12.",
                            "abstract": null
                        },
                        {
                            "pmid": "24004666",
                            "title": "Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.",
                            "journal": "Blood",
                            "pubDate": "2013 Oct 10",
                            "volume": "122",
                            "issue": "15",
                            "pages": "2673-82",
                            "authors": "Chigrinova E et al",
                            "elocationId": "doi: 10.1182/blood-2013-03-489518",
                            "link": null,
                            "reference": "Chigrinova E et al. Blood. 2013 Oct 10;122(15)2673-82.",
                            "abstract": null
                        },
                        {
                            "pmid": "20697090",
                            "title": "TP53 mutation and survival in chronic lymphocytic leukemia.",
                            "journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
                            "pubDate": "2010 Oct 10",
                            "volume": "28",
                            "issue": "29",
                            "pages": "4473-9",
                            "authors": "Zenz T et al",
                            "elocationId": "doi: 10.1200/JCO.2009.27.8762",
                            "link": null,
                            "reference": "Zenz T et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Oct 10;28(29)4473-9.",
                            "abstract": null
                        },
                        {
                            "pmid": "19188171",
                            "title": "The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.",
                            "journal": "Clinical cancer research : an official journal of the American Association for Cancer Research",
                            "pubDate": "2009 Feb 1",
                            "volume": "15",
                            "issue": "3",
                            "pages": "995-1004",
                            "authors": "Rossi D et al",
                            "elocationId": "doi: 10.1158/1078-0432.CCR-08-1630",
                            "link": null,
                            "reference": "Rossi D et al. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Feb 1;15(3)995-1004.",
                            "abstract": null
                        }
                    ]
                }
            ]
        },
        {
            "relevantTumorType": false,
            "tumorType": {
                "id": 695,
                "subtype": "Essential Thrombocythemia",
                "code": "ET",
                "color": "LightSalmon",
                "mainType": "Myeloproliferative Neoplasms",
                "level": 4,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            },
            "evidences": [
                {
                    "id": 25664,
                    "uuid": "b6f54e8b-aa53-4c55-9cd8-5edc0c81fb77",
                    "evidenceType": "PROGNOSTIC_IMPLICATION",
                    "cancerTypes": [
                        {
                            "id": 695,
                            "subtype": "Essential Thrombocythemia",
                            "code": "ET",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "excludedCancerTypes": [],
                    "relevantCancerTypes": [
                        {
                            "id": 695,
                            "subtype": "Essential Thrombocythemia",
                            "code": "ET",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 330,
                            "subtype": "Essential Thrombocythemia Myelofibrosis",
                            "code": "ETMF",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "gene": {
                        "entrezGeneId": 7157,
                        "hugoSymbol": "TP53",
                        "grch37Isoform": "ENST00000269305",
                        "grch37RefSeq": "NM_000546.5",
                        "grch38Isoform": "ENST00000269305",
                        "grch38RefSeq": "NM_000546.5",
                        "geneAliases": [
                            "LFS1",
                            "p53"
                        ],
                        "genesets": [],
                        "geneType": "TSG"
                    },
                    "alterations": [
                        {
                            "gene": {
                                "entrezGeneId": 7157,
                                "hugoSymbol": "TP53",
                                "grch37Isoform": "ENST00000269305",
                                "grch37RefSeq": "NM_000546.5",
                                "grch38Isoform": "ENST00000269305",
                                "grch38RefSeq": "NM_000546.5",
                                "geneAliases": [
                                    "LFS1",
                                    "p53"
                                ],
                                "genesets": [],
                                "geneType": "TSG"
                            },
                            "consequence": {
                                "term": "NA",
                                "isGenerallyTruncating": false,
                                "description": "NA"
                            },
                            "alteration": "Oncogenic Mutations",
                            "name": "Oncogenic Mutations",
                            "refResidues": null,
                            "proteinStart": -1,
                            "proteinEnd": 100000,
                            "variantResidues": null,
                            "referenceGenomes": [
                                "GRCh38",
                                "GRCh37"
                            ]
                        }
                    ],
                    "description": "This assertion is supported by (PMID: 22887079, 29296692, 24478400).",
                    "additionalInfo": null,
                    "treatments": [],
                    "knownEffect": null,
                    "lastEdit": 1600293135000,
                    "lastReview": null,
                    "levelOfEvidence": "LEVEL_Px1",
                    "fdaLevel": null,
                    "solidPropagationLevel": null,
                    "liquidPropagationLevel": null,
                    "articles": [
                        {
                            "pmid": "29296692",
                            "title": "Targeted deep sequencing in polycythemia vera and essential thrombocythemia.",
                            "journal": "Blood advances",
                            "pubDate": "2016 Nov 29",
                            "volume": "1",
                            "issue": "1",
                            "pages": "21-30",
                            "authors": "Tefferi A et al",
                            "elocationId": "doi: 10.1182/bloodadvances.2016000216",
                            "link": null,
                            "reference": "Tefferi A et al. Blood advances. 2016 Nov 29;1(1)21-30.",
                            "abstract": null
                        },
                        {
                            "pmid": "22887079",
                            "title": "Clinical significance of genetic aberrations in secondary acute myeloid leukemia.",
                            "journal": "American journal of hematology",
                            "pubDate": "2012 Nov",
                            "volume": "87",
                            "issue": "11",
                            "pages": "1010-6",
                            "authors": "Milosevic JD et al",
                            "elocationId": "doi: 10.1002/ajh.23309",
                            "link": null,
                            "reference": "Milosevic JD et al. American journal of hematology. 2012 Nov;87(11)1010-6.",
                            "abstract": null
                        },
                        {
                            "pmid": "24478400",
                            "title": "Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.",
                            "journal": "Blood",
                            "pubDate": "2014 Apr 3",
                            "volume": "123",
                            "issue": "14",
                            "pages": "2220-8",
                            "authors": "Lundberg P et al",
                            "elocationId": "doi: 10.1182/blood-2013-11-537167",
                            "link": null,
                            "reference": "Lundberg P et al. Blood. 2014 Apr 3;123(14)2220-8.",
                            "abstract": null
                        }
                    ]
                }
            ]
        },
        {
            "relevantTumorType": false,
            "tumorType": {
                "id": 632,
                "subtype": "Primary Myelofibrosis",
                "code": "PMF",
                "color": "LightSalmon",
                "mainType": "Myeloproliferative Neoplasms",
                "level": 4,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            },
            "evidences": [
                {
                    "id": 25668,
                    "uuid": "7940b806-79c6-4cda-a468-befdd8806bb7",
                    "evidenceType": "PROGNOSTIC_IMPLICATION",
                    "cancerTypes": [
                        {
                            "id": 632,
                            "subtype": "Primary Myelofibrosis",
                            "code": "PMF",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "excludedCancerTypes": [],
                    "relevantCancerTypes": [
                        {
                            "id": 755,
                            "subtype": "Primary Myelofibrosis, Prefibrotic/Early Stage",
                            "code": "PMFPES",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 632,
                            "subtype": "Primary Myelofibrosis",
                            "code": "PMF",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 493,
                            "subtype": "Primary Myelofibrosis,Overt Fibrotic Stage",
                            "code": "PMFOFS",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "gene": {
                        "entrezGeneId": 7157,
                        "hugoSymbol": "TP53",
                        "grch37Isoform": "ENST00000269305",
                        "grch37RefSeq": "NM_000546.5",
                        "grch38Isoform": "ENST00000269305",
                        "grch38RefSeq": "NM_000546.5",
                        "geneAliases": [
                            "LFS1",
                            "p53"
                        ],
                        "genesets": [],
                        "geneType": "TSG"
                    },
                    "alterations": [
                        {
                            "gene": {
                                "entrezGeneId": 7157,
                                "hugoSymbol": "TP53",
                                "grch37Isoform": "ENST00000269305",
                                "grch37RefSeq": "NM_000546.5",
                                "grch38Isoform": "ENST00000269305",
                                "grch38RefSeq": "NM_000546.5",
                                "geneAliases": [
                                    "LFS1",
                                    "p53"
                                ],
                                "genesets": [],
                                "geneType": "TSG"
                            },
                            "consequence": {
                                "term": "NA",
                                "isGenerallyTruncating": false,
                                "description": "NA"
                            },
                            "alteration": "Oncogenic Mutations",
                            "name": "Oncogenic Mutations",
                            "refResidues": null,
                            "proteinStart": -1,
                            "proteinEnd": 100000,
                            "variantResidues": null,
                            "referenceGenomes": [
                                "GRCh38",
                                "GRCh37"
                            ]
                        }
                    ],
                    "description": "This assertion is supported by (PMID: 22887079, 25516983, 22052707).",
                    "additionalInfo": null,
                    "treatments": [],
                    "knownEffect": null,
                    "lastEdit": 1600293135000,
                    "lastReview": null,
                    "levelOfEvidence": "LEVEL_Px1",
                    "fdaLevel": null,
                    "solidPropagationLevel": null,
                    "liquidPropagationLevel": null,
                    "articles": [
                        {
                            "pmid": "22887079",
                            "title": "Clinical significance of genetic aberrations in secondary acute myeloid leukemia.",
                            "journal": "American journal of hematology",
                            "pubDate": "2012 Nov",
                            "volume": "87",
                            "issue": "11",
                            "pages": "1010-6",
                            "authors": "Milosevic JD et al",
                            "elocationId": "doi: 10.1002/ajh.23309",
                            "link": null,
                            "reference": "Milosevic JD et al. American journal of hematology. 2012 Nov;87(11)1010-6.",
                            "abstract": null
                        },
                        {
                            "pmid": "25516983",
                            "title": "Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms.",
                            "journal": "Proceedings of the National Academy of Sciences of the United States of America",
                            "pubDate": "2014 Dec 16",
                            "volume": "111",
                            "issue": "50",
                            "pages": "E5401-10",
                            "authors": "Rampal R et al",
                            "elocationId": "doi: 10.1073/pnas.1407792111",
                            "link": null,
                            "reference": "Rampal R et al. Proceedings of the National Academy of Sciences of the United States of America. 2014 Dec 16;111(50)E5401-10.",
                            "abstract": null
                        },
                        {
                            "pmid": "22052707",
                            "title": "TP53 mutations and polymorphisms in primary myelofibrosis.",
                            "journal": "American journal of hematology",
                            "pubDate": "2012 Feb",
                            "volume": "87",
                            "issue": "2",
                            "pages": "204-6",
                            "authors": "Raza S et al",
                            "elocationId": "doi: 10.1002/ajh.22216",
                            "link": null,
                            "reference": "Raza S et al. American journal of hematology. 2012 Feb;87(2)204-6.",
                            "abstract": null
                        }
                    ]
                }
            ]
        },
        {
            "relevantTumorType": false,
            "tumorType": {
                "id": 185,
                "subtype": "Myeloproliferative Neoplasms",
                "code": "MPN",
                "color": "LightSalmon",
                "mainType": "Myeloproliferative Neoplasms",
                "level": 3,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            },
            "evidences": [
                {
                    "id": 25666,
                    "uuid": "b487b052-7db8-4a2c-8441-ee6b295823c6",
                    "evidenceType": "PROGNOSTIC_IMPLICATION",
                    "cancerTypes": [
                        {
                            "id": 185,
                            "subtype": "Myeloproliferative Neoplasms",
                            "code": "MPN",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 3,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "excludedCancerTypes": [],
                    "relevantCancerTypes": [
                        {
                            "id": 545,
                            "subtype": "Chronic Eosinophilic Leukemia, NOS",
                            "code": "CELNOS",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 806,
                            "subtype": "Polycythemia Vera",
                            "code": "PV",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 330,
                            "subtype": "Essential Thrombocythemia Myelofibrosis",
                            "code": "ETMF",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 43,
                            "subtype": "Chronic Neutrophilic Leukemia",
                            "code": "CNL",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 77,
                            "subtype": "Polycythaemia Vera Myelofibrosis",
                            "code": "PVMF",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 493,
                            "subtype": "Primary Myelofibrosis,Overt Fibrotic Stage",
                            "code": "PMFOFS",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 560,
                            "subtype": "Chronic Myelogenous Leukemia",
                            "code": "CML",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 755,
                            "subtype": "Primary Myelofibrosis, Prefibrotic/Early Stage",
                            "code": "PMFPES",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 597,
                            "subtype": "Chronic Myeloid Leukemia, BCR-ABL1+",
                            "code": "CMLBCRABL1",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 695,
                            "subtype": "Essential Thrombocythemia",
                            "code": "ET",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 632,
                            "subtype": "Primary Myelofibrosis",
                            "code": "PMF",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 185,
                            "subtype": "Myeloproliferative Neoplasms",
                            "code": "MPN",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 3,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 831,
                            "subtype": "Myeloproliferative Neoplasms, Unclassifiable",
                            "code": "MPNU",
                            "color": "LightSalmon",
                            "mainType": "Myeloproliferative Neoplasms",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "gene": {
                        "entrezGeneId": 7157,
                        "hugoSymbol": "TP53",
                        "grch37Isoform": "ENST00000269305",
                        "grch37RefSeq": "NM_000546.5",
                        "grch38Isoform": "ENST00000269305",
                        "grch38RefSeq": "NM_000546.5",
                        "geneAliases": [
                            "LFS1",
                            "p53"
                        ],
                        "genesets": [],
                        "geneType": "TSG"
                    },
                    "alterations": [
                        {
                            "gene": {
                                "entrezGeneId": 7157,
                                "hugoSymbol": "TP53",
                                "grch37Isoform": "ENST00000269305",
                                "grch37RefSeq": "NM_000546.5",
                                "grch38Isoform": "ENST00000269305",
                                "grch38RefSeq": "NM_000546.5",
                                "geneAliases": [
                                    "LFS1",
                                    "p53"
                                ],
                                "genesets": [],
                                "geneType": "TSG"
                            },
                            "consequence": {
                                "term": "NA",
                                "isGenerallyTruncating": false,
                                "description": "NA"
                            },
                            "alteration": "Oncogenic Mutations",
                            "name": "Oncogenic Mutations",
                            "refResidues": null,
                            "proteinStart": -1,
                            "proteinEnd": 100000,
                            "variantResidues": null,
                            "referenceGenomes": [
                                "GRCh38",
                                "GRCh37"
                            ]
                        }
                    ],
                    "description": "This assertion is supported by (PMID: 22887079, 25516983, 22052707).",
                    "additionalInfo": null,
                    "treatments": [],
                    "knownEffect": null,
                    "lastEdit": 1600293135000,
                    "lastReview": null,
                    "levelOfEvidence": "LEVEL_Px1",
                    "fdaLevel": null,
                    "solidPropagationLevel": null,
                    "liquidPropagationLevel": null,
                    "articles": [
                        {
                            "pmid": "22887079",
                            "title": "Clinical significance of genetic aberrations in secondary acute myeloid leukemia.",
                            "journal": "American journal of hematology",
                            "pubDate": "2012 Nov",
                            "volume": "87",
                            "issue": "11",
                            "pages": "1010-6",
                            "authors": "Milosevic JD et al",
                            "elocationId": "doi: 10.1002/ajh.23309",
                            "link": null,
                            "reference": "Milosevic JD et al. American journal of hematology. 2012 Nov;87(11)1010-6.",
                            "abstract": null
                        },
                        {
                            "pmid": "25516983",
                            "title": "Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms.",
                            "journal": "Proceedings of the National Academy of Sciences of the United States of America",
                            "pubDate": "2014 Dec 16",
                            "volume": "111",
                            "issue": "50",
                            "pages": "E5401-10",
                            "authors": "Rampal R et al",
                            "elocationId": "doi: 10.1073/pnas.1407792111",
                            "link": null,
                            "reference": "Rampal R et al. Proceedings of the National Academy of Sciences of the United States of America. 2014 Dec 16;111(50)E5401-10.",
                            "abstract": null
                        },
                        {
                            "pmid": "22052707",
                            "title": "TP53 mutations and polymorphisms in primary myelofibrosis.",
                            "journal": "American journal of hematology",
                            "pubDate": "2012 Feb",
                            "volume": "87",
                            "issue": "2",
                            "pages": "204-6",
                            "authors": "Raza S et al",
                            "elocationId": "doi: 10.1002/ajh.22216",
                            "link": null,
                            "reference": "Raza S et al. American journal of hematology. 2012 Feb;87(2)204-6.",
                            "abstract": null
                        }
                    ]
                }
            ]
        },
        {
            "relevantTumorType": false,
            "tumorType": {
                "id": 586,
                "subtype": "Mantle Cell Lymphoma",
                "code": "MCL",
                "color": "LimeGreen",
                "mainType": "Mature B-Cell Neoplasms",
                "level": 5,
                "tissue": "Lymphoid",
                "tumorForm": "LIQUID"
            },
            "evidences": [
                {
                    "id": 25670,
                    "uuid": "e05be7f2-30ba-4b12-84ab-aeba2c0e29ab",
                    "evidenceType": "PROGNOSTIC_IMPLICATION",
                    "cancerTypes": [
                        {
                            "id": 586,
                            "subtype": "Mantle Cell Lymphoma",
                            "code": "MCL",
                            "color": "LimeGreen",
                            "mainType": "Mature B-Cell Neoplasms",
                            "level": 5,
                            "tissue": "Lymphoid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "excludedCancerTypes": [],
                    "relevantCancerTypes": [
                        {
                            "id": 167,
                            "subtype": "In Situ Mantle Cell Neoplasia",
                            "code": "ISMCL",
                            "color": "LimeGreen",
                            "mainType": "Mature B-Cell Neoplasms",
                            "level": 6,
                            "tissue": "Lymphoid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 586,
                            "subtype": "Mantle Cell Lymphoma",
                            "code": "MCL",
                            "color": "LimeGreen",
                            "mainType": "Mature B-Cell Neoplasms",
                            "level": 5,
                            "tissue": "Lymphoid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "gene": {
                        "entrezGeneId": 7157,
                        "hugoSymbol": "TP53",
                        "grch37Isoform": "ENST00000269305",
                        "grch37RefSeq": "NM_000546.5",
                        "grch38Isoform": "ENST00000269305",
                        "grch38RefSeq": "NM_000546.5",
                        "geneAliases": [
                            "LFS1",
                            "p53"
                        ],
                        "genesets": [],
                        "geneType": "TSG"
                    },
                    "alterations": [
                        {
                            "gene": {
                                "entrezGeneId": 7157,
                                "hugoSymbol": "TP53",
                                "grch37Isoform": "ENST00000269305",
                                "grch37RefSeq": "NM_000546.5",
                                "grch38Isoform": "ENST00000269305",
                                "grch38RefSeq": "NM_000546.5",
                                "geneAliases": [
                                    "LFS1",
                                    "p53"
                                ],
                                "genesets": [],
                                "geneType": "TSG"
                            },
                            "consequence": {
                                "term": "NA",
                                "isGenerallyTruncating": false,
                                "description": "NA"
                            },
                            "alteration": "Oncogenic Mutations",
                            "name": "Oncogenic Mutations",
                            "refResidues": null,
                            "proteinStart": -1,
                            "proteinEnd": 100000,
                            "variantResidues": null,
                            "referenceGenomes": [
                                "GRCh38",
                                "GRCh37"
                            ]
                        }
                    ],
                    "description": "This assertion is supported by (PMID: 28819011, 26022239, 24684350, 8639789, 7579380).",
                    "additionalInfo": null,
                    "treatments": [],
                    "knownEffect": null,
                    "lastEdit": 1600293135000,
                    "lastReview": null,
                    "levelOfEvidence": "LEVEL_Px3",
                    "fdaLevel": null,
                    "solidPropagationLevel": null,
                    "liquidPropagationLevel": null,
                    "articles": [
                        {
                            "pmid": "24684350",
                            "title": "SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.",
                            "journal": "British journal of haematology",
                            "pubDate": "2014 Jul",
                            "volume": "166",
                            "issue": "1",
                            "pages": "98-108",
                            "authors": "Nordström L et al",
                            "elocationId": "doi: 10.1111/bjh.12854",
                            "link": null,
                            "reference": "Nordström L et al. British journal of haematology. 2014 Jul;166(1)98-108.",
                            "abstract": null
                        },
                        {
                            "pmid": "8639789",
                            "title": "p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis.",
                            "journal": "Blood",
                            "pubDate": "1996 May 15",
                            "volume": "87",
                            "issue": "10",
                            "pages": "4302-10",
                            "authors": "Greiner TC et al",
                            "elocationId": "",
                            "link": null,
                            "reference": "Greiner TC et al. Blood. 1996 May 15;87(10)4302-10.",
                            "abstract": null
                        },
                        {
                            "pmid": "7579380",
                            "title": "p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).",
                            "journal": "Blood",
                            "pubDate": "1995 Oct 15",
                            "volume": "86",
                            "issue": "8",
                            "pages": "2892-9",
                            "authors": "Louie DC et al",
                            "elocationId": "",
                            "link": null,
                            "reference": "Louie DC et al. Blood. 1995 Oct 15;86(8)2892-9.",
                            "abstract": null
                        },
                        {
                            "pmid": "26022239",
                            "title": "High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.",
                            "journal": "Blood",
                            "pubDate": "2015 Jul 30",
                            "volume": "126",
                            "issue": "5",
                            "pages": "604-11",
                            "authors": "Delfau-Larue MH et al",
                            "elocationId": "doi: 10.1182/blood-2015-02-628792",
                            "link": null,
                            "reference": "Delfau-Larue MH et al. Blood. 2015 Jul 30;126(5)604-11.",
                            "abstract": null
                        },
                        {
                            "pmid": "28819011",
                            "title": "<i>TP53</i> mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.",
                            "journal": "Blood",
                            "pubDate": "2017 Oct 26",
                            "volume": "130",
                            "issue": "17",
                            "pages": "1903-1910",
                            "authors": "Eskelund CW et al",
                            "elocationId": "doi: 10.1182/blood-2017-04-779736",
                            "link": null,
                            "reference": "Eskelund CW et al. Blood. 2017 Oct 26;130(17)1903-1910.",
                            "abstract": null
                        }
                    ]
                }
            ]
        },
        {
            "relevantTumorType": false,
            "tumorType": {
                "id": 527,
                "subtype": "Acute Myeloid Leukemia",
                "code": "AML",
                "color": "LightSalmon",
                "mainType": "Leukemia",
                "level": 3,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            },
            "evidences": [
                {
                    "id": 25656,
                    "uuid": "e43a1d21-8fe5-454e-8200-34d72533a72e",
                    "evidenceType": "PROGNOSTIC_IMPLICATION",
                    "cancerTypes": [
                        {
                            "id": 527,
                            "subtype": "Acute Myeloid Leukemia",
                            "code": "AML",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 3,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "excludedCancerTypes": [],
                    "relevantCancerTypes": [
                        {
                            "id": 260,
                            "subtype": "APL with PML-RARA",
                            "code": "APLPMLRARA",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 198,
                            "subtype": "AML with Recurrent Genetic Abnormalities",
                            "code": "AMLRGA",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 6,
                            "subtype": "Therapy-Related Myelodysplastic Syndrome",
                            "code": "TMDS",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 390,
                            "subtype": "AML (megakaryoblastic) with t(1;22)(p13.3;q13.3);RBM15-MKL1",
                            "code": "AMLRBM15MKL1",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 844,
                            "subtype": "Myeloid Proliferations Related to Down Syndrome",
                            "code": "MPRDS",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 12,
                            "subtype": "AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22);CBFB-MYH11",
                            "code": "AMLCBFBMYH11",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 590,
                            "subtype": "AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",
                            "code": "AMLGATA2MECOM",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 527,
                            "subtype": "Acute Myeloid Leukemia",
                            "code": "AML",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 3,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 784,
                            "subtype": "Myeloid Sarcoma",
                            "code": "MS",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 16,
                            "subtype": "AML without Maturation",
                            "code": "AWM",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 17,
                            "subtype": "AML with Myelodysplasia-Related Changes",
                            "code": "AMLMRC",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 468,
                            "subtype": "Therapy-Related Acute Myeloid Leukemia",
                            "code": "TAML",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 789,
                            "subtype": "AML with Mutated NPM1",
                            "code": "AMLNPM1",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 149,
                            "subtype": "Acute Panmyelosis with Myelofibrosis",
                            "code": "APMF",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 791,
                            "subtype": "AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1",
                            "code": "AMLRUNX1RUNX1T1",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 601,
                            "subtype": "AML, NOS",
                            "code": "AMLNOS",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 537,
                            "subtype": "Acute Megakaryoblastic Leukemia",
                            "code": "AMKL",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 27,
                            "subtype": "Acute Monoblastic/Monocytic Leukemia",
                            "code": "AMOL",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 28,
                            "subtype": "Pure Erythroid Leukemia",
                            "code": "PERL",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 29,
                            "subtype": "AML with Biallelic Mutations of CEBPA",
                            "code": "AMLCEBPA",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 671,
                            "subtype": "AML with Minimal Differentiation",
                            "code": "AMLMD",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 864,
                            "subtype": "AML with Maturation",
                            "code": "AM",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 418,
                            "subtype": "Therapy-Related Myeloid Neoplasms",
                            "code": "TMN",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 4,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 805,
                            "subtype": "AML with Mutated RUNX1",
                            "code": "AMLRUNX1",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 429,
                            "subtype": "AML with t(6;9)(p23;q34.1);DEK-NUP214",
                            "code": "AMLDEKNUP214",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 246,
                            "subtype": "AML with t(9;11)(p21.3;q23.3);MLLT3-KMT2A",
                            "code": "AMLMLLT3KMT2A",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 822,
                            "subtype": "Acute Basophilic Leukemia",
                            "code": "ABL",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 184,
                            "subtype": "AML with BCR-ABL1",
                            "code": "AMLBCRABL1",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 251,
                            "subtype": "Transient Abnormal Myelopoiesis",
                            "code": "TAM",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 318,
                            "subtype": "Acute Myelomonocytic Leukemia",
                            "code": "AMML",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        },
                        {
                            "id": 255,
                            "subtype": "Myeloid Leukemia Associated with Down Syndrome",
                            "code": "MLADS",
                            "color": "LightSalmon",
                            "mainType": "Leukemia",
                            "level": 5,
                            "tissue": "Myeloid",
                            "tumorForm": "LIQUID"
                        }
                    ],
                    "gene": {
                        "entrezGeneId": 7157,
                        "hugoSymbol": "TP53",
                        "grch37Isoform": "ENST00000269305",
                        "grch37RefSeq": "NM_000546.5",
                        "grch38Isoform": "ENST00000269305",
                        "grch38RefSeq": "NM_000546.5",
                        "geneAliases": [
                            "LFS1",
                            "p53"
                        ],
                        "genesets": [],
                        "geneType": "TSG"
                    },
                    "alterations": [
                        {
                            "gene": {
                                "entrezGeneId": 7157,
                                "hugoSymbol": "TP53",
                                "grch37Isoform": "ENST00000269305",
                                "grch37RefSeq": "NM_000546.5",
                                "grch38Isoform": "ENST00000269305",
                                "grch38RefSeq": "NM_000546.5",
                                "geneAliases": [
                                    "LFS1",
                                    "p53"
                                ],
                                "genesets": [],
                                "geneType": "TSG"
                            },
                            "consequence": {
                                "term": "NA",
                                "isGenerallyTruncating": false,
                                "description": "NA"
                            },
                            "alteration": "Oncogenic Mutations",
                            "name": "Oncogenic Mutations",
                            "refResidues": null,
                            "proteinStart": -1,
                            "proteinEnd": 100000,
                            "variantResidues": null,
                            "referenceGenomes": [
                                "GRCh38",
                                "GRCh37"
                            ]
                        }
                    ],
                    "description": "This assertion is supported by (PMID: 22186996, 18596741).",
                    "additionalInfo": null,
                    "treatments": [],
                    "knownEffect": null,
                    "lastEdit": 1600293135000,
                    "lastReview": null,
                    "levelOfEvidence": "LEVEL_Px1",
                    "fdaLevel": null,
                    "solidPropagationLevel": null,
                    "liquidPropagationLevel": null,
                    "articles": [
                        {
                            "pmid": "22186996",
                            "title": "TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.",
                            "journal": "Blood",
                            "pubDate": "2012 Mar 1",
                            "volume": "119",
                            "issue": "9",
                            "pages": "2114-21",
                            "authors": "Rücker FG et al",
                            "elocationId": "doi: 10.1182/blood-2011-08-375758",
                            "link": null,
                            "reference": "Rücker FG et al. Blood. 2012 Mar 1;119(9)2114-21.",
                            "abstract": null
                        },
                        {
                            "pmid": "18596741",
                            "title": "TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis.",
                            "journal": "Leukemia",
                            "pubDate": "2009 Jan",
                            "volume": "23",
                            "issue": "1",
                            "pages": "203-6",
                            "authors": "Bowen D et al",
                            "elocationId": "doi: 10.1038/leu.2008.173",
                            "link": null,
                            "reference": "Bowen D et al. Leukemia. 2009 Jan;23(1)203-6.",
                            "abstract": null
                        }
                    ]
                }
            ]
        }
    ],
    "vus": false
}